Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
CareDx
CDNA
$1.97B
| $120K | ﹤0.01% |
10,531
-10,531
| -50% | -$156K |
|
|
NKLA
2302
DELISTED
Nikola Corporation Common Stock
NKLA
| $120K | ﹤0.01% |
1,862
-1,855
| -50% | -$155K |
|
2303
Geron
GERN
$860M
| $119K | ﹤0.01% |
49,417
-49,453
| -50% | -$111K |
|
|
DENN
2304
DELISTED
Denny's
DENN
| $119K | ﹤0.01% |
12,925
-12,925
| -50% | -$140K |
|
2305
GoPro
GPRO
$124M
| $118K | ﹤0.01% |
23,741
-23,745
| -50% | -$125K |
|
|
TGI
2306
DELISTED
Triumph Group
TGI
| $118K | ﹤0.01% |
11,219
-11,219
| -50% | -$116K |
|
2307
RPC Inc
RES
$1.2B
| $118K | ﹤0.01% |
13,225
-13,225
| -50% | -$119K |
|
2308
Interface
TILE
$1.96B
| $117K | ﹤0.01% |
11,917
-11,917
| -50% | -$125K |
|
|
CHS
2309
DELISTED
Chicos FAS, Inc.
CHS
| $116K | ﹤0.01% |
23,700
-23,702
| -50% | -$133K |
|
2310
Select Water Solutions
WTTR
$2.26B
| $116K | ﹤0.01% |
12,529
-12,527
| -50% | -$106K |
|
2311
JetBlue
JBLU
$2.29B
| $114K | ﹤0.01% |
17,517
-17,521
| -50% | -$128K |
|
2312
Stagwell
STGW
$2.1B
| $112K | ﹤0.01% |
17,992
-17,994
| -50% | -$130K |
|
|
PAYA
2313
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $112K | ﹤0.01% |
14,198
-14,198
| -50% | -$110K |
|
2314
Vodafone
VOD
$37.2B
| $111K | ﹤0.01% |
11,000
-11,000
| -50% | -$124K |
|
|
QVCGA
2315
DELISTED
QVC Group Inc Series A
QVCGA
| $111K | ﹤0.01% |
1,369
-1,370
| -50% | -$140K |
|
|
VRAY
2316
DELISTED
ViewRay, Inc.
VRAY
| $111K | ﹤0.01% |
24,744
-24,750
| -50% | -$108K |
|
|
XRN
2317
Chiron Real Estate Inc
XRN
$516M
| $109K | ﹤0.01% |
2,310
-2,310
| -50% | -$104K |
|
2318
Opko Health
OPK
$993M
| $109K | ﹤0.01% |
87,852
-87,870
| -50% | -$138K |
|
2319
Evolution Petroleum
EPM
$131M
| $108K | ﹤0.01% |
+14,253
| New | +$107K |
|
|
BRSP
2320
BrightSpire Capital
BRSP
$633M
| $107K | ﹤0.01% |
17,223
-17,225
| -50% | -$120K |
|
2321
Acco Brands
ACCO
$390M
| $107K | ﹤0.01% |
19,192
-19,192
| -50% | -$99.7K |
|
2322
BridgeBio Pharma
BBIO
$16.1B
| $105K | ﹤0.01% |
13,828
-13,830
| -50% | -$132K |
|
|
PNT
2323
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $102K | ﹤0.01% |
+13,938
| New | +$103K |
|
2324
Brookdale Senior Living
BKD
$3.49B
| $101K | ﹤0.01% |
37,238
-37,240
| -50% | -$139K |
|
|
VMEO
2325
DELISTED
Vimeo
VMEO
| $101K | ﹤0.01% |
29,440
-29,444
| -50% | -$114K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.